Sigyn Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
Sigyn Therapeutics' 2024 annual report details the company's ongoing development of medical devices for cancer and infectious disease, including its lead candidate, Sigyn TherapyTM, and its efforts to secure additional capital.
OTC.Pink
10-K: Sigyn Therapeutics Reports 2023 Annual Results, Outlines Progress in Blood Purification Technologies
Sigyn Therapeutics, a development-stage company, released its 2023 annual report, highlighting advancements in its blood purification technologies and financial results.